Search Results 61-70 of 17351 for Teratogenic

  1. Non-Alcoholic Fatty Liver Disease Progression Prevention Using Lisinopril - Mayo Clinic

    - Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 (Karnofsky ≥ 60%). - The effects of lisinopril has been shown to be teratogenic in animal ...

  2. A Study Of CSF-1R Inhibitor, AXatilimab For GVHD After HLA-matched Related And Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS) - Mayo Clinic

    Any of the following because this study involves an investigational agent whose genotoxic, mutagenic, and teratogenic effect on the developing fetus and newborn ...

  3. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

    -REGISTRATION: Any of the following because this study involves an agent that has known genotoxic, mutagenic, and teratogenic effects: -Pregnant persons ...

  4. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight - Mayo Clinic

    This study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown. Other ...

  5. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown. Pregnant persons. Nursing persons. Persons of childbearing potential {and persons able to ...

  6. Comparing Retreatment Of 177Lu-DOTATATE PRRT Versus Everolimus In Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial - Mayo Clinic

    receptor radionuclide therapy with the potential for teratogenic or abortifacient effects. Because there is an unknown but potential risk for adverse events ...

  7. A Study Of Sonodynamic Therapy With SONALA-001 And Exablate 4000 Type 2.0 In Subjects With Progressive Or Recurrent Glioblastoma Multiforme (RGBM) - Mayo Clinic

    Any of the following because this study involves an investigational agent, the genotoxic, mutagenic, and teratogenic effects of which on the developing fetus ...

  8. PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers - Mayo Clinic

    Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant persons. Nursing persons ...

  9. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer - Mayo Clinic

    Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

  10. Home Care Treatment With Oral Chemotherapy For Recurrent Or Metastatic Oral Cavity Cancer - Mayo Clinic

    ... teratogenic effects of which on the developing fetus and newborn are unknown. Pregnant persons. Nursing persons. Persons of childbearing potential and persons ...